Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedNew sections such as How to Read a Study Record, Common Questions, and How to Join a Study appear, improving guidance and navigation on the study page. The recruitment status note No longer looking for participants indicates that enrollment has closed, aligning the page with the study's current status.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new minor update to the page documentation or metadata. No study content or user-facing information appears to be changed.SummaryDifference0.0%

- Check17 days agoChange DetectedA new citation about surgical outcomes from KEYNOTE-522 was added to the Publications section, and the 'Online ahead of print' note was removed from that citation.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedUpdated the Italy site listing by changing Macerata, Italy, 62100 to Province of Macerata, Italy, 62100, adding a more precise regional designation to the trial site. The change also introduces a new version tag, Revision: v3.5.4.SummaryDifference0.1%

- Check39 days agoChange DetectedTaiwan site location updated to Taoyuan, Taiwan (postal code 333), replacing Taoyuan District in the location list.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing Revision: v3.5.2. This updates the page's revision history to reflect the latest release.SummaryDifference0.0%

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.